ReviewBiosensors2025
Advances in the Direct Nanoscale Integration of Molecularly Imprinted Polymers (MIPs) with Transducers for the Development of High-Performance Nanosensors.
Review in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Towards engineering molecularly imprinted polymer-based sensors: linking design strategies to analytical and operational performance.Analytical and bioanalytical chemistry · 2026Review
- Nanosensors in food safety detection: a comprehensive review of recent advances and future prospects.Mikrochimica acta · 2026Review
- Molecularly Imprinted Polymers as Biomimetic Test Zones in Paper-Based Nucleic Acid Assays-Comparing Vertical and Lateral Flow Formats.Biosensors · 2026Article
- Article
- Development of a magnetic molecularly imprinted polymer for the removal of dexamethasone from river nile water.Scientific reports · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Molecularly imprinted polymers (MIPs) have emerged as robust, cost-effective analogues of bioreceptors, offering high selectivity and stability. When applied in sensors, one key step is the integration of MIPs with the transducer, which critically affects sensor performance. Demanding challenges come when such integration involves nanoscaling processes, meaning that the transducer is nanostructured or the MIP itself is nanosized on a bulk transducer. In both cases, the integration results in the development of nanosensors, with advantages arising from the nanoscale, such as a high MIP surface-to-volume ratio, with surface-located, easily accessible binding sites, fast binding kinetics, and, thus, a rapid sensor response. Major advantages come also from nanostructured transducers, with nanoscale geometry enabling highly sensitive signal generation processes, not allowed on their bulk counterparts. In this review, we discuss advances in imprinting technologies, focusing on techniques that, enabling the nanoscale control of MIP synthesis, are conveniently applied to directly integrate MIPs with nanosensors in a one-step process. Two main approaches are reviewed, consisting in MIP nanostructuring on bulk transducers and in the direct growth of MIPs on nanotransducers, highlighting how different strategies achieve good conformity at the nanoscale and address spatial complexity to ensure stable and accurate signal acquisition. Finally, we consider future directions in MIP-based nanosensor development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.